✦ LIBER ✦

Thrombelastograph platelet mapping in a patient receiving antiplatelet therapy

✍ Scribed by Evan G. Pivalizza; Vladimir Melnikov; Sara Guzman-Reyes; Brian Marasigan

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 38 KB
Volume: 16
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.22089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply: Thrombelastograph platelet mappin

Reply: Thrombelastograph platelet mapping in a patient receiving antiplatelet therapy

✍ Katherine James 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

We thank Pivalizza et al. for their interest in our article and comments. They are correct that loading doses of antiplatelet agents are usually used in the context of revascularization procedures and acute ischemic events. However, we chose a more cautious approach because of the paucity of data r

Platelet functions beyond hemostasis, an

Platelet functions beyond hemostasis, antiplatelet therapies in high-risk patient subgroups: theFourth Annual Platelet Colloquium

✍ Patricia A. French 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 231 KB

Selecting optimal antiplatelet therapy b

Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease

✍ Paul A. Gurbel; Udaya S. Tantry 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 297 KB

Endoscopic resection of bladder cancer i

Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy

✍ Luca Carmignani; Stefano Picozzi; Robert Stubinski; Stefano Casellato; Giorgio B 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 154 KB

Thrombosis of tibial arteries in a patie

Thrombosis of tibial arteries in a patient receiving tamoxifen therapy

✍ Narayan Deshmukh; Sanjay P. Tripathi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

Trisomy 6 in a CML patient receiving ima

Trisomy 6 in a CML patient receiving imatinib mesylate therapy

✍ Zámečníkova Adriana; Al Bahar Soad; Ramesh Pandita 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 289 KB

The emergence of chromosome abnormalities in Philadelphia-negative cells in chronic myelogenous leukemia patients during imatinib therapy have been described by several authors. While these abnormalities are frequently transient, in rare instances they may be presented on repeated occasions suggesti